FIG. 3.

Representation of the ERV and FDA from the intracellular (A) and extracellular (B) proteome reliability matrix. The ERV (%) for each spot was calculated for the serovar factor. The FDA were carried out with the five most representative spots for the intracellular proteome (translation elongation factor Ts [LMOf2365_1678], the adenylate kinase [LMOf2365_2584], the 2-C-methyl-d-erythritol 4-phosphate cytidylyltransferase 2 [IspD2], and two unidentified spots) and the four most representative spots for the extracellular proteome (Lmo2522, a peptidase of the M48 family [LMOf2365_2477], a serine protease [LMOf2365_1900], and one unidentified spot). This allowed for very good discrimination of the serovars.